If recent headlines are any indication, 2025 will be a pivotal year for setting the course of private equity investment in ...

Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...

After hours: January 31 at 4:20:00 PM EST Loading Chart for AMED ...

The Dallas-based private equity firm Havencrest Capital Management has its home care platform. That’s Avid Health at Home, which has aggressive growth plans from the outset. The company was first ...